Ever find yourself second-guessing whether to offer a vaccine when you’re not sure about a resident’s status? Pneumococcal vaccinations for older adults just got a whole lot simpler, thanks to new guidance from the Advisory Committee on Immunization Practices (ACIP). Their updated recommendation now includes all adults aged 50 or older who haven’t received the vaccine—or if their vaccination status is unknown.

That’s right—those of us officially labeled “seniors” (their word, not ours) are encouraged to receive a single dose of a pneumococcal conjugate vaccine (PCV). It’s a change that could significantly impact resident health, especially considering how common certain risk factors are in senior living communities.

Some of the top conditions that increase the risk of pneumococcal disease include asthma, COPD, diabetes, cigarette use, and alcoholism. Sound familiar? It probably describes a fair number of your residents. In the past, many of us hesitated to offer the vaccine without a confirmed history. But now, if a resident’s vaccine status is unclear, the recommendation is to go ahead and provide that one-time dose.

So why the shift in guidance? Roughly 30% to 50% of adults aged 50–64 have at least one condition that increases their risk for pneumococcal disease. Research shows that a “blanket coverage” approach ensures broader protection and better vaccine uptake across the board. Of course, there are always risks. Post-licensure data for PCV20 suggests a possible—but very rare—link to Guillain-Barré syndrome (fewer than one in a million doses), though the evidence is uncertain.

Still, the benefit of preventing a potentially life-threatening illness often outweighs the minimal risk. So, why take the chance? Talk with your residents, families, your medical director, and staff. Share the updated recommendations and encourage residents to get vaccinated. It’s just a small poke—and it might just help prevent the next case of severe pneumonia.

Stay well and stay informed!